New Atlas1d
First new stroke and UTI drugs in 30 years get FDA approval
A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...
'Time is brain': How to identify and respond to a stroke
Imagine you're at a dinner party and the person sitting across the table from you suddenly stops making sense, and not ...
Stroke risk higher for at least a decade after minor stroke-like attacks, study indicates
The risk of a full-blown stroke will remain high for at least a decade after a person has a slight brush with stroke, in the ...
Onlymyhealth on MSN6d
Why You Shouldn't Take A Mini Stroke Lightly
While a mini stroke isn’t as major and dangerous as a regular stroke it can be an indication of a future stroke; hence it shouldn’t be taken lightly ...
Woman's World on MSN6h
‘Reba' Star Christopher Rich on His Stroke: ‘I'm Feeling Really Good'
If you're like us, you love when an actor on your old favorite show pops up on your new favorite show. So when Christopher ...
24 Hours in A&E shows worrying moment patient loses speech as they suffer stroke in TV first
In a TV first, the new episode of 24 Hours In A&E shows someone in the middle of suffering a stroke, after 61-year-old ...
Stroke Risk Higher For At Least A Decade After Minor Stroke-Like Attacks
FRIDAY, March 28, 2025 (HealthDay News) -- The risk of a full-blown stroke will remain high for at least a decade after a person has a slight brush with stroke, in the form of a transient ischemic ...
I blamed long hours and caffeine for my symptoms. Then a doctor's sudden panic confirmed I'd missed deadly warning signs... and left it too late
Less than ten minutes after my CAT scan, my room in the ER was filled with a team of medical staff. Each of them had grave, ...
New Drug Lepodisiran Expected To Cut Risk of Heart Attack, Stroke By 94 Percent
A single dose of an experimental drug has been found to reduce the risk of genetic heart disease by at least 94 per cent. Lepodisiran, developed by Eli Lilly, has shown promising results in reducing ...
The US approved an Alzheimer’s drug. Seven patients subsequently died.
Leqembi — sold through a partnership between Eisai Co. and Cambridge-based Biogen — is one of the first medications approved ...